EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent
…, L Moris, DE Oprea-Lager, HG van der Poel… - European urology, 2021 - Elsevier
… f g , Stefano Fanti h , Nicola Fossati i j , Giorgio Gandaglia i j , Silke Gillessen k l m , Nikos
Grivas n , Jeremy Grummet o , Ann M. Henry p , Theodorus H. van der Kwast q , Thomas B. …
Grivas n , Jeremy Grummet o , Ann M. Henry p , Theodorus H. van der Kwast q , Thomas B. …
EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer
…, L Moris, DE Oprea-Lager, HG van der Poel… - European urology, 2021 - Elsevier
… Cornford a , Roderick CN van den Bergh b , Erik Briers c , Thomas Van den Broeck d , Marcus
… Henry p , Theodorus H. van der Kwast q , Thomas B. Lam r s , Michael Lardas t , Matthew …
… Henry p , Theodorus H. van der Kwast q , Thomas B. Lam r s , Michael Lardas t , Matthew …
Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy
…, F Montorsi, VR Patel, JU Stolzenburg, H Van der Poel… - European urology, 2012 - Elsevier
… Carroll e , Anthony Costello f , Mani Menon g , Francesco Montorsi h , Vipul R. Patel i ,
Jens-Uwe Stolzenburg j , Henk Van der Poel k , Timothy G. Wilson l , Filiberto Zattoni a , …
Jens-Uwe Stolzenburg j , Henk Van der Poel k , Timothy G. Wilson l , Filiberto Zattoni a , …
EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent
…, HG van der Poel, TH van der Kwast… - European urology, 2017 - Elsevier
… van der Poel is a company consultant for Intuitive Surgical and participates in trials for Astellas
and Steba Biotech. He receives grants/research support from Astellas. Olivier Rouvière is …
and Steba Biotech. He receives grants/research support from Astellas. Olivier Rouvière is …
EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer
…, MD Mason, HG van der Poel, TH van der Kwast… - European urology, 2017 - Elsevier
… H. van der Poel is a company consultant for Intuitive Surgical, has participated in trials for
Astellas and Steba Biotech, has … Henry and TH van der Kwast have nothing to disclose. …
Astellas and Steba Biotech, has … Henry and TH van der Kwast have nothing to disclose. …
Urine markers for bladder cancer surveillance: a systematic review
BWG Van Rhijn, HG Van der Poel, TH van Der Kwast - European urology, 2005 - Elsevier
INTRODUCTION:: The follow-up of patients with urothelial cell carcinoma (UCC) of the
bladder is done by cystoscopy and, in most cases, cytology. The last decade, many urine-based …
bladder is done by cystoscopy and, in most cases, cytology. The last decade, many urine-based …
[PDF][PDF] Guidelines on prostate cancer
…, H Van der Poel, TH Van der Kwast… - … Association of Urology, 2015 - file.medtrib.cn
Please note that this text presents an abridged version of the full text Prostate Cancer (PCa)
guidelines and consultation of the more detailed, underlying document, is strongly advised. …
guidelines and consultation of the more detailed, underlying document, is strongly advised. …
Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy
BACKGROUND: Although the initial robot-assisted radical prostatectomy (RARP) series
showed 12-mo potency rates ranging from 70% to 80%, the few available comparative studies …
showed 12-mo potency rates ranging from 70% to 80%, the few available comparative studies …
The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review
…, VB Matveev, HG van der Poel, TH van der Kwast… - European urology, 2017 - Elsevier
… Willemse b 1 , Thomas Van den Broeck c , Roderick CN van den Bergh d , Cathy Yuhong …
van der Poel p , Theo H. van der Kwast q , Olivier Rouvière r , Ivo G. Schoots s t , Thomas …
van der Poel p , Theo H. van der Kwast q , Olivier Rouvière r , Ivo G. Schoots s t , Thomas …
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial
…, C van Rooijen, D Peters, A Broeks, HG van der Poel… - Nature medicine, 2020 - nature.com
… h, Normalized TLS area in post-therapy samples between patients who received steroids
(>20 mg … van der Laan and S. van der Kolk), the Genomics Core Facility and the Core Facility …
(>20 mg … van der Laan and S. van der Kolk), the Genomics Core Facility and the Core Facility …